Robert S. Mills - 01 Dec 2023 Form 4 Insider Report for TFF Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Robert S. Mills by Kirk Allen Coleman, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Dec 2023
Net transactions value
$0
Form type
4
Filing time
04 Dec 2023, 17:30:06 UTC
Previous filing
15 Aug 2023
Next filing
22 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Award $0 +52,858 $0.000000 52,858 01 Dec 2023 Common Stock 52,858 $0.3600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options represent the annual option grant to non-executive members of the Board of Directors.